Research finds genetic factors that protect from chronification of migraines

According to existing estimates, migraine is a highly prevalent ailment, with about 15 percent of global population suffering from it at one time or another. In Russia, the ratio is as high as 20 percent. The current diagnostics and treatment methods are strictly clinical, i. e. they are based on a patient's complaints.

This research was conducted by KFU's Neurobiology Lab and Gene and Cell Technologies Lab. The team looked for genetic markers of migraine for about two years. Colleagues from Saint-Petersburg and Kazan State Medical University also contributed.

Chronic migraine is a much more serious disease than episodic migraine. Migraine is prone to becoming a chronic syndrome, so it's important to detect those who may become afflicted in the risk groups with episodic migraines. Such patients may be assigned prevention medications to avoid chronic migraine. Thanks to this particular research, we found genetic factors protecting from the chronification of migraines."

Aliya Yakubova, Neurologist, Junior Research Associate

For the testing, 46 patients with migraine and 50 patients without the disease were selected. They donated blood for DNA sequencing. In the sequencing process, the scientists determined polymorphisms in the pain receptor TRPV1. In this case, the replacement of nucleotide A by nucleotide G leads to the change in amino acids.

At this stage, the pilot studies have been completed. The selection process will continue, and patients with chronic or episodic migraine can partake.

"We will test the results on a larger selection of individuals. If our takeaways stand ground, we'd like to introduce them into clinical practice. If a patient has genotypes AA or AG, which don't prevent migraine chronicity, they can receive long-term prevention therapies. If they have the GG genotype, chronicity is unlikely, and only symptomatic therapy can be prescribed," continues Yakubova.

The work helped find significant differences in polymorphisms in patients with chronic versus episodic migraine. This means that some degree of genetic predisposition exists, and there are risk factors and prevention factors of chronicity for all the three genotypes. The patenting process for the technique is currently underway.

Source:
Journal reference:

Yakubova, A., et al. (2020) Searching for Predictors of Migraine Chronification: a Pilot Study of 1911A>G Polymorphism of TRPV1 Gene in Episodic Versus Chronic Migraine. Journal of Molecular Neuroscience. doi.org/10.1007/s12031-020-01683-9.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Evo model set to transform synthetic biology and disease diagnosis